Skip to search formSkip to main contentSkip to account menu

Sectral

Known as: Monitan 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

AcebutololAcebutolol Hydrochloride
Acebutolol Hydrochloride 200 MG Oral Capsule [Sectral]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
[Acebutolol in the therapy of mild and moderate hypertension].
Acebutolol (sectral) is one of the new types of cardioselective beta-blockers which has at the same time also qualities of ISA… 
1992
1992
[Hypertensive heart. Experience in the clinical use of sectral (acebutolol)].
1987
1987
[Hemodynamic changes during treatment with isodinit, sectral, stenopril and kratemon].
1983
1983
[Use of Falicard and Sectral in patients with COPD and ischemic heart disease].
Thirty patients with chronic obstructive pulmonary disease (ChOPD) and concomitant ischemic heart disease (IHD) were studied that… 
1982
1982
Antihypertensive action of acebutolol (Sectral) when used concomitantly with hydrochlorothiazide.
1 In a placebo-controlled study, the respective anti-hypertensive effects of hydrochlorothiazide and hydrochlorothiazide plus the… 
1979
1979
Onset and duration of beta-adrenergic receptor blockade following single oral dose acebutolol hydrochloride (Sectral).
1. The onset and duration of action of once daily acebutolol (400 mg) on resting and exercise heart rate and blood pressure were… 
1975
1975
Comparison of the effects of acebutolol (Sectral) and practolol (Eraldin) on airways obstruction in asthmatics.
The effects of oral practolol (Eraldin, I.C.I. Ltd) (300 mg) and acebutolol (Sectral, May & Baker Ltd) (300 mg) were compared in… 
1973
1973
Effectiveness of sectral (M & B 17803A) as a beta-blocking agent in man.
1955
1955
Accidental massive overdose of monitan in an infant.
1952
1952
TREATMENT OF DARIER'S DISEASE (KERATOSIS FOLLICULARIS)
Treatment in many cases of Darier's disease (keratosis follicularis) has been unsatisfactory. Although vitamin A therapy as… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)